# Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

> **NCT06995976** · EARLY_PHASE1 · RECRUITING · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Malignant Tumour

## Interventions

- **DRUG:** 68Ga-dPNE
- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT06995976
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995976, "Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06995976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*